Conclusion
Through analysing of off-label prescriptions of tocilizumab in our hospital, we found most of the indications have scientific evidence to support. But some indications were supported by low grade scientific evidence, more studies are required to confirm the clinical values. For the indication that has no evidence support, we suggest the administration should strength supervision.